000			02035 a2200553 4500
005			20250513234524.0
264		0	_c20010510
008			200105s 0 0 eng d
022			_a0007-0920
024	7		_a10.1054/bjoc.2001.1698 _2doi
040			_aNLM _beng _cNLM
100	1		_aMurphy, L O
245	0	0	_aPancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions. _h[electronic resource]
260			_bBritish journal of cancer _cApr 2001
300			_a926-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aCell Division _xphysiology
650	0	4	_aCulture Media, Serum-Free
650	0	4	_aEnzyme Activation
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEpidermal Growth Factor _xmetabolism
650	0	4	_aErbB Receptors _xmetabolism
650	0	4	_aFlavonoids _xpharmacology
650	0	4	_aGastrin-Releasing Peptide _xmetabolism
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aInsulin-Like Growth Factor I _xmetabolism
650	0	4	_aMAP Kinase Signaling System _xphysiology
650	0	4	_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors
650	0	4	_aMitogen-Activated Protein Kinase 3
650	0	4	_aMitogen-Activated Protein Kinases _xantagonists & inhibitors
650	0	4	_aPancreatic Neoplasms _xmetabolism
650	0	4	_aQuinazolines
650	0	4	_aSubstrate Specificity
650	0	4	_aTranscription Factor AP-1 _xbiosynthesis
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTyrphostins _xpharmacology
700	1		_aCluck, M W
700	1		_aLovas, S
700	1		_aOtvös, F
700	1		_aMurphy, R F
700	1		_aSchally, A V
700	1		_aPermert, J
700	1		_aLarsson, J
700	1		_aKnezetic, J A
700	1		_aAdrian, T E
773	0		_tBritish journal of cancer _gvol. 84 _gno. 7 _gp. 926-35
856	4	0	_uhttps://doi.org/10.1054/bjoc.2001.1698 _zAvailable from publisher's website
999			_c11221902 _d11221902